In a week, the cases of dengue fever in Paraná increased from 257 to 354 on Monday (16) by the State Department of Health, increasing 37 , 7%. The disease occurs in 79 communities, which belong to 16 state health regions. The regions with the most deposits are Maringá, Foz do Iguacu, Paranavaí, Cornelio Procopio, Londrina, Umuarama and Campo Mourão. Paraná has registered 3,355 dengue reports until yesterday (17).
Five communities are alerted to the disease – Inajá, Florida, Uraí, Floraí and Indianópolis. The reported incidence in these cities is more than 100 and less than 300 cases per 100,000 inhabitants.
The technical report also confirmed the first case of Chikungunya from that time, which was monitored from the 28th century July 2019. The case is "imported" and the probable place of infection was the municipality of Arapiraca in the state Alagoas. The person who has become infected with Chickungunya lives in Araucaria. is a 55 year old woman. She has been treated medically and she is fine.
The Sesa Bulletin also refers to the Dengue Climate Alert Service of the Federal University of Paraná Laboratory, which provides municipalities with information to identify their risk situation. This week, the publication draws attention to favorable conditions for the spread of Aedes aegypti to communities in the west, northwest and north. The Paraná Ministry of Health emphasizes that vector control is the main component in the fight against dengue fever and other diseases.
NATIONAL VACCINE CAN BE READY UNTIL 2020
Concerning the epidemiological dengue scenario this year, which increased by 599.5% compared to 2018, Health Minister Luiz Henrique Mandetta, reported that the butane vaccine produced by the Butantan Institute is already in the final stages of testing. This step is expected to be completed by 2020. The single-dose vaccine protects against the four dengue serotypes and is in its third phase of human development.
"We are very confident with the vaccine and look forward to it. that she can arrive next year. By then, we will have a very harsh summer, which will be fraught with great difficulties due to the reintroduction of the dengue serotype 2, which has been causing many people to be susceptible to the disease since 2018, "said the Minister of Health during the 7th Brazilian Medical Law Congress and Health, in Vitória (ES) on Monday.
At the end of the third phase of immunobiological production, the Butantan Institute must demonstrate its efficacy through a study that aims to provide safety data and final indices of vaccine protection. After this process, the vaccine must be registered with the National Health Surveillance Agency for inclusion in the Unified Health System (SUS).
With Well Paraná